<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230205057336N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-27</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of dry needling compared to sham dry needling on the sensitization of the nervous system at peripheral, spinal and cerebral levels in patients with Non-specific Chronic Low Back Pain(NSCLBP)</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of dry needling compared to sham dry needling on the sensitization of the nervous system at peripheral, spinal and cerebral levels in patients with Non-specific Chronic Low Back Pain(NSCLBP)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>56</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72616</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are randomly assigned to intervention and sham groups by permutation randomization method which is done with the help of randomization program (block number 14 and block size 4).
Allocation of samples is done in a ratio of 1:1. In order to hide the allocation, opaque and sealed envelopes are used, Blinding description: In order to blind the study, evaluation tests are performed by one physiotherapist and dry needling treatment techniques are performed by another physiotherapist. Statistical analysis is performed by a person who does not know the grouping of patients. On the other hand, the participants do not know about the group they are randomly placed in.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Non-specific Chronic Low Back Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  Patients in this group receives three treatment sessions with an interval of 72 hours. In the range of minimum 3 to maximum 7 muscles from lumbar multifidus muscles, gluteus maximus, gluteus medius, quadratus lumbarum and paravertebral muscles, which is considered as paravertebral muscle, lumbar iliocostalis muscle. All muscles are selected and dry needled based on the number of active trigger points they have. In this dry needling study, the fast in-fast out technique is used. We manipulate the needle in different directions until the first twitch is seen. The size of the needles is selected according to the volume of fat tissue in the patient's body. In cases where it is necessary, strong pressure is applied to compress the skin tissue. Intervention 2: Control group: Control group: the needle is taken out of the box without tearing its packaging, and its tip is shortened enough that it no longer touches the patient's skin and is placed back in the packaging. The patient is placed exactly like the treatment group for all muscles and an alcohol pad is used. In this treatment, the guide is pressed on the patient's body to create a sensation similar to dry needling. Other interventions will be completely similar to the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is After preparing and completing the files, they will be available to the readers or other scientific people if needed</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Narges Meftahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Abiverdi st1, Chamran Blvd</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194733669</zip>
        <telephone>+98 71 3627 1551</telephone>
        <email>meftahin@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Narges meftahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Abiverdi st 1, Chamran Blvd</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194733669</zip>
        <telephone>+98 71 3627 1551</telephone>
        <email>meftahin@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>At least three months have passed since the onset of their back pain
Have an average age of 18-45 years
There are no signs of involvement of nerve roots, disc inflammation and sciatic nerve
Have at least 3 to a maximum of 7 active trigger points in the gluteus maximus, gluteus medius, quadratus lumbarum, paravertebral and multifidus muscles
The score of the CSI questionnaire is equal to or greater than 40
Numerical evaluation of pain should have at least score of 3
No previous history of dry needling treatment</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of hemophilia and coagulation disorders
A patient with lymphedema
Pregnancy
Cancer, fracture, infection or immunodeficiency diseases such as AIDS and hepatitis
Specific back pains including back pains originating from disc involvement and nerve roots, spondylolisthesis and spondylolysis
A patient with back pain that is the origin of visceral pain
Use of anticoagulants
Patients with fear of needles in the form of phobia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  Patients in this group receives three treatment sessions with an interval of 72 hours. In the range of minimum 3 to maximum 7 muscles from lumbar multifidus muscles, gluteus maximus, gluteus medius, quadratus lumbarum and paravertebral muscles, which is considered as paravertebral muscle, lumbar iliocostalis muscle. All muscles are selected and dry needled based on the number of active trigger points they have. In this dry needling study, the fast in-fast out technique is used. We manipulate the needle in different directions until the first twitch is seen. The size of the needles is selected according to the volume of fat tissue in the patient's body. In cases where it is necessary, strong pressure is applied to compress the skin tissue.</i_keyword>
      <i_keyword>Control group: Control group: the needle is taken out of the box without tearing its packaging, and its tip is shortened enough that it no longer touches the patient's skin and is placed back in the packaging. The patient is placed exactly like the treatment group for all muscles and an alcohol pad is used. In this treatment, the guide is pressed on the patient's body to create a sensation similar to dry needling. Other interventions will be completely similar to the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Conditioned pain modulation. Timepoint: Before, immediately and six weeks after the intervention. Method of measurement: The difference in pressure pain tolerance threshold with algometer before and after the application of conditioned pain by pressure cuff.</prim_outcome>
      <prim_outcome>Temporal summation of pain. Timepoint: Before, immediately and six weeks after the intervention. Method of measurement: The difference in pain report based on numeric rate scale after one stimulation and several repeated painful stimulations.</prim_outcome>
      <prim_outcome>Pressure pain threshold both in the pain area and in the distal area. Timepoint: Before, immediately and six weeks after the intervention. Method of measurement: Record the number shown on the algometer display at the moment of pain after applying pressure.</prim_outcome>
      <prim_outcome>Central sensitization. Timepoint: Before, immediately and six weeks after the intervention. Method of measurement: Central sensitization inventory.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain. Timepoint: Before, immediately and six weeks after the intervention. Method of measurement: Numeric rate scale.</sec_outcome>
      <sec_outcome>Function rate. Timepoint: Before, immediately and six weeks after the intervention. Method of measurement: Extensor muscle endurance test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of medical sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-26</approval_date>
        <contact_name>Ethics Committee in Shiraz Faculty of Rehabilitation Science research</contact_name>
        <contact_address>Abiverdi st 1, Chamran Blvd Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
